This decision comes at a time when both Italy and the Czech Republic have legalized medicinal marijuana, which MJNA has a full line of products to support.
While stock prices for MJNA have been modestly hovering around $0.30 per share for the past few weeks, the news from the company caused a rather significant boost. According to Hot Stocked, the market reacted with an 11% increase, which has since leveled out.
Traders are becoming more and more enthusiastic, it seems, as MJNA describes its successes and looks towards ways to increase its presence in Europe and other areas abroad. Medical Marijuana Inc. produces a wide range of cannabis-based products that are specifically meant to be used as over the counter health and wellness medicines. The company’s most successful product has been a high-concentration CBD oil, Yahoo! News reports, although MJNA has many other products that have also been doing well on the market.
This will mark the first time that the company has offered its products outside of the United States, which has investors quite interested in what could occur in the future, both near- and long-term.
One of the major reasons why all of this is noteworthy is the fact that other European nations are looking towards potentially legalizing marijuana and importing marijuana products from America, specifically from states such as Colorado and Washington. Denmark is a prime example and could provide MJNA and similar companies with more opportunities down the road.
To read more, visit http://www.wealthdaily.com/articles/medical-marijuana-investing-expands/4099